FXS887

· Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FXS887, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of FXS887 in the Treatment of Solid Tumors [Phase 1]